Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
|
|
Helix Technologies, Inc. (HLIX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/13/2018 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of EisnerAmper, LLP",
"Audited financial statements of Bio-Tech Medical Software, Inc. as of and for the years ended December 31, 2017 and 2016 and the related notes thereto",
"Balance sheets as of March 31, 2018 (unaudited) and December 31, 2017, and the unaudited statements of operations and cash flows for the three-months ended March 31, 2018 and March 31, 2017, and unaudited statement of stockholders' equity for the three-month period ended March 30, 2018",
"Unaudited pro forma condensed combined balance sheets and statements of operations of the Company for the three months ended March 31, 2018 and unaudited pro forma condensed combined statements of operations of the Company for the year ended December 31, 2017 and the notes thereto" |
|
| 11/08/2017 |
8-K/A
| Financial Statements and Exhibits |
| 02/23/2017 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|